Escalon Medical Corp (ESMC) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Escalon Medical Corp   (ESMC)


Escalon Medical's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Escalon Medical's ROI in the third quarter of 2026?
Escalon Medical Corp achieved a return on average invested assets (ROI) of 64.71 % in its third quarter of 2026, this is above ESMC's average return on investment of -14.09%.
Escalon Medical Corp invested over the 12 months ending in its third quarter of 2026 $2 million

ROI has improved compared to 8.72% in the second quarter of 2025, due to net income growth.

Within the Healthcare sector 31 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2025 from 3060 to 3118.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter		 (Jun 30 2025)
IV. Quarter		 (Mar 31 2025)
III. Quarter
Y / Y Investment Change TTM 8.42 % 42.45 % 23.28 % 13.41 % 7.26 %
Y / Y Net Income Change TTM - - 244.17 % - -
Investment (TTM) in Millions 0 5 2 2 2
Return On Investment (TTM) - 8.72 % 4.24 % 17.14 % -1.74 %
ESMC's Overall Ranking # 3118 # 3060 # # #
Seq. Investment Change TTM -19.82 % 26.04 % 4.96 % 2.21 % 5.35 %
Seq. Net Income Change TTM 494.74 % 159.12 % -74.01 % - -
Net Income (TTM) in Millions 2 0 0 0 0

ESMC Company Profile >> Back to ESMC Roi Comparisons >> See Annual ESMC Return On Investment



Return On Investment ESMC's Ranking
Within: No.
Industry # 6
Sector # 32
Overall # 3118

Return On Investment Statistics
High Average Low
50.13 %
-14.09 %
-95.84 %
(Mar 31 2026)   (Dec 31 2013)







Financial Statements
Escalon Medical's III. Quarter Investments $ 0 Millions ESMC's Balance sheet
Escalon Medical's III. Quarter Income $ 1 Millions Quarterly ESMC's Income Statement
ESMC's Income by Division See ESMC's Income by Division


ESMC Annual Return On Investment (Jun 30 2025)
2025		 (Jun 30 2024)
2024		 (Jun 30 2023)
2023		 (Jun 30 2022)
2022		 (Jun 30 2021)
2021
Total Investments in Millions 2 2 2 2 2
Y / Y Investment Growth 3.33 % -12.5 % 44.39 % -33.09 % -17.3 %
Net Income in Millions 0 0 0 0 0
Y / Y Net Income Growth - - 1408.84 % - -
Annual Return On Investment 3.86 % -6.27 % 11.96 % 1.14 % -2.2 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 3.86 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ESMC's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ESMC's Competitors
Subscribers only: Roi for Escalon Medical's Suppliers
Subscribers only: Return On Investment for ESMC's Customers

Other Ratios
ESMC's Roa ESMC's Inventory Turnover Ratio ESMC's Growth Rates ESMC's Dividend Statistics
ESMC's Profitability Ratios ESMC's Asset Turnover Ratio ESMC's Dividend Growth
ESMC's Roe ESMC's Valuation Ratios ESMC's Financial Strength Ratios ESMC's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI
Kyntra Bio Inc   155.01 %
Rigel Pharmaceuticals Inc  132.72 %
Interpace Biosciences Inc   130.15 %
Oncotelic Therapeutics Inc   129.74 %
Coherus Oncology inc   128.80 %
Petros Pharmaceuticals inc   124.23 %
Arbutus Biopharma Corp  119.86 %
Quince Therapeutics Inc   114.14 %
Capforce Inc   102.27 %
Qhslab Inc   83.28 %
Advanced Biomed Inc.  81.85 %
Entera Bio Ltd   78.23 %
Pulmatrix Inc   77.85 %
Exelixis Inc   77.71 %
Ironwood Pharmaceuticals inc   72.86 %
Lensar Inc   71.13 %
Fortress Biotech Inc   70.93 %
Earth Science Tech Inc   68.75 %
Q32 Bio Inc   58.17 %
Oramed Pharmaceuticals Inc  54.33 %
Aurinia Pharmaceuticals Inc   54.02 %
Vaxart Inc   51.45 %
Escalon Medical Corp   51.07 %
Tg Therapeutics Inc   50.62 %
Zevra Therapeutics Inc   50.45 %
Idexx Laboratories Inc  50.05 %
Theravance Biopharma inc   43.85 %
Elite Pharmaceuticals Inc   43.22 %
Dariohealth Corp   40.59 %
Innoviva Inc   36.71 %

Date modified: 2026-09-12T06:11:25+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.